封面
市場調查報告書
商品編碼
1714332

羊膜穿刺針市場-全球產業規模、佔有率、趨勢、機會及預測,按類型、按程序、按地區及競爭細分,2020-2030 年預測

Amniocentesis Needle Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Type, By Procedure, By Region & Competition, 2020-2030F

出版日期: | 出版商: TechSci Research | 英文 188 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球羊膜穿刺針市場價值為 1.7728 億美元,預計到 2030 年將達到 2.3609 億美元,預測期內複合年成長率為 4.85%。羊膜穿刺針是產前診斷中用於提取羊水的重要工具,有助於檢測懷孕期間的染色體異常、神經管缺陷和遺傳疾病。隨著人們越來越意識到早期和準確的產前檢測的重要性,對羊膜穿刺(以及羊膜穿刺針)的需求也不斷增加。在教育措施和醫療保健進步的支持下,產前診斷的接受度不斷提高,推動了市場的成長。此外,在製造商競爭的推動下,針頭設計和功能的不斷創新正在提高安全性、精確度和成本效益。儘管人們對非侵入性替代方法的興趣日益濃厚,但羊膜穿刺術仍然是一種黃金標準的診斷程序,確保了羊膜穿刺針解決方案的持續相關性。

市場概覽
預測期 2026-2030
2024年市場規模 1.7728億美元
2030年市場規模 2.3609億美元
2025-2030 年複合年成長率 4.85%
成長最快的領域 羊膜穿刺術
最大的市場 北美洲

關鍵市場促進因素

全球孕產婦年齡不斷增加

主要市場挑戰

替代篩檢方法

主要市場趨勢

非侵入性產前檢測(NIPT)的採用率不斷上升

目錄

第 1 章:產品概述

第2章:研究方法

第3章:執行摘要

第4章:顧客之聲

第5章:羊膜穿刺針市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依類型(100 至 150 毫米針頭、大於 150 毫米針頭、小於 100 毫米針頭)
    • 依手術(羊膜穿刺術、羊水減量術、胎兒輸血術、羊膜腔灌注術、臍帶穿刺術)
    • 按地區
    • 按公司分類(2024)
  • 市場地圖

第6章:北美羊膜穿刺針市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美:國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章:歐洲羊膜穿刺針市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲:國家分析
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙

第8章:亞太地區羊膜穿刺針市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區:國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章:南美洲羊膜穿刺針市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲:國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章:中東與非洲羊膜穿刺針市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA:國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章:市場動態

  • 驅動程式
  • 挑戰

第 12 章:市場趨勢與發展

  • 最新動態
  • 產品發布
  • 併購

第 13 章: 大環境分析

第 14 章:波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第15章:全球羊膜穿刺針市場:SWOT分析

第 16 章:競爭格局

  • Becton Dickinson and Company
  • The Cooper Companies, Inc.
  • Cook Medical Incorporated
  • RI.MOS. srl
  • Medtronic Plc
  • Somatex Medical Technologies
  • COOK Medical
  • Smiths Medical
  • Biopsybell
  • IMD

第 17 章:策略建議

第18章調查會社について,免責事項

簡介目錄
Product Code: 16100

The Global Amniocentesis Needle Market was valued at USD 177.28 million in 2024 and is projected to reach USD 236.09 million by 2030, growing at a CAGR of 4.85% during the forecast period. Amniocentesis needles are critical tools used in prenatal diagnostics to extract amniotic fluid, aiding in the detection of chromosomal abnormalities, neural tube defects, and genetic disorders during pregnancy. As awareness grows around the importance of early and accurate prenatal testing, demand for amniocentesis procedures-and by extension, amniocentesis needles-is on the rise. Increasing acceptance of prenatal diagnostics, supported by educational initiatives and healthcare advancements, is boosting market growth. Moreover, ongoing innovations in needle design and functionality, driven by manufacturer competition, are enhancing safety, precision, and cost-efficiency. Despite rising interest in non-invasive alternatives, amniocentesis remains a gold standard diagnostic procedure, ensuring sustained relevance for amniocentesis needle solutions.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 177.28 Million
Market Size 2030USD 236.09 Million
CAGR 2025-20304.85%
Fastest Growing SegmentAmniocentesis Procedures
Largest MarketNorth America

Key Market Drivers

Increasing Maternal Age Worldwide

The upward trend in maternal age across the globe is significantly influencing demand for prenatal diagnostic procedures like amniocentesis. In countries such as the United States and Germany, the average age of first-time mothers has steadily increased, resulting in a higher number of pregnancies classified as high-risk. This demographic shift correlates with an elevated incidence of chromosomal abnormalities, including Down syndrome and Trisomy 18, particularly in women over 35. As these pregnancies necessitate more thorough prenatal diagnostics, the use of amniocentesis-and consequently, specialized needles for the procedure-becomes increasingly common. In developed nations like Italy, Spain, and South Korea, where the average maternal age is nearing or surpassing 32 years, the demand for accurate and safe diagnostic tools is surging. This global trend toward delayed parenthood, fueled by social and economic factors such as education, career focus, and access to fertility treatments, is a critical driver of growth in the amniocentesis needle market.

Key Market Challenges

Alternative Screening Methods

The growing adoption of alternative screening methods, particularly non-invasive prenatal testing (NIPT), presents a challenge for the amniocentesis needle market. NIPT offers high accuracy in detecting chromosomal abnormalities by analyzing cell-free fetal DNA through a maternal blood sample, reducing the need for invasive testing. These methods are preferred by many expectant parents due to their safety and comfort, as they eliminate the small but real risk associated with amniocentesis. However, while NIPT provides a reliable screening option, it does not deliver a definitive diagnosis, for which amniocentesis remains essential. The increasing use of NIPT may reduce the overall frequency of amniocentesis procedures, impacting the demand for related medical tools, including needles. Nonetheless, in cases requiring confirmation or where detailed genetic analysis is necessary, amniocentesis continues to be indispensable, maintaining its critical role in high-risk pregnancies.

Key Market Trends

Rising Adoption of Non-Invasive Prenatal Testing (NIPT)

Non-Invasive Prenatal Testing (NIPT) is gaining traction as a preferred screening method, significantly shaping the dynamics of the amniocentesis needle market. NIPT enables early detection of chromosomal abnormalities using a maternal blood sample, offering a non-invasive alternative to traditional diagnostic methods. This trend reflects a growing preference for safer, less intrusive prenatal assessments. The appeal of NIPT lies in its ability to deliver accurate results with no risk of complications, enhancing patient comfort and compliance. While this shift may reduce the frequency of invasive procedures like amniocentesis, it's important to note that NIPT is a screening-not diagnostic-tool. Therefore, when definitive diagnosis is necessary, especially in high-risk pregnancies, amniocentesis remains a critical follow-up procedure. As such, the adoption of NIPT is transforming prenatal care but continues to position amniocentesis as an essential diagnostic pathway for comprehensive fetal health evaluation.

Key Market Players

  • Becton Dickinson and Company
  • The Cooper Companies, Inc.
  • Cook Medical Incorporated
  • RI.MOS. srl
  • Medtronic Plc
  • Somatex Medical Technologies
  • COOK Medical
  • Smiths Medical
  • Biopsybell
  • IMD

Report Scope:

In this report, the Global Amniocentesis Needle Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Amniocentesis Needle Market, By Type:

  • 100 to 150 mm Needles
  • Larger Than 150 mm Needles
  • Smaller Than 100 mm Needles

Amniocentesis Needle Market, By Procedure:

  • Amniocentesis Procedures
  • Amnioreduction Procedures
  • Fetal Blood Transfusion Procedures
  • Amnioinfusion Procedures
  • Cordocentesis Procedures

Amniocentesis Needle Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Amniocentesis Needle Market.

Available Customizations:

Global Amniocentesis Needle Market report with the given Market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional Market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Amniocentesis Needle Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (100 to 150 mm Needles, Larger Than 150 mm Needles, Smaller Than 100 mm Needles)
    • 5.2.2. By Procedure (Amniocentesis Procedures, Amnioreduction Procedures, Fetal Blood Transfusion Procedures, Amnioinfusion Procedures, Cordocentesis Procedures)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Amniocentesis Needle Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Procedure
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Amniocentesis Needle Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Procedure
    • 6.3.2. Canada Amniocentesis Needle Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Procedure
    • 6.3.3. Mexico Amniocentesis Needle Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Procedure

7. Europe Amniocentesis Needle Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Procedure
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Amniocentesis Needle Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Procedure
    • 7.3.2. United Kingdom Amniocentesis Needle Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Procedure
    • 7.3.3. Italy Amniocentesis Needle Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Procedure
    • 7.3.4. France Amniocentesis Needle Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Procedure
    • 7.3.5. Spain Amniocentesis Needle Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Procedure

8. Asia-Pacific Amniocentesis Needle Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Procedure
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Amniocentesis Needle Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Procedure
    • 8.3.2. India Amniocentesis Needle Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Procedure
    • 8.3.3. Japan Amniocentesis Needle Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Procedure
    • 8.3.4. South Korea Amniocentesis Needle Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Procedure
    • 8.3.5. Australia Amniocentesis Needle Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Procedure

9. South America Amniocentesis Needle Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Procedure
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Amniocentesis Needle Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Procedure
    • 9.3.2. Argentina Amniocentesis Needle Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Procedure
    • 9.3.3. Colombia Amniocentesis Needle Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Procedure

10. Middle East and Africa Amniocentesis Needle Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Procedure
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Amniocentesis Needle Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Procedure
    • 10.3.2. Saudi Arabia Amniocentesis Needle Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Procedure
    • 10.3.3. UAE Amniocentesis Needle Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Procedure

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. PESTLE Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Product

15. Global Amniocentesis Needle Market: SWOT Analysis

16. Competitive Landscape

  • 16.1. Becton Dickinson and Company
    • 16.1.1. Business Overview
    • 16.1.2. Product & Service Offerings
    • 16.1.3. Recent Developments
    • 16.1.4. Financials (If Listed)
    • 16.1.5. Key Personnel
    • 16.1.6. SWOT Analysis
  • 16.2. The Cooper Companies, Inc.
  • 16.3. Cook Medical Incorporated
  • 16.4. RI.MOS. srl
  • 16.5. Medtronic Plc
  • 16.6. Somatex Medical Technologies
  • 16.7. COOK Medical
  • 16.8. Smiths Medical
  • 16.9. Biopsybell
  • 16.10.IMD

17. Strategic Recommendations

18. About Us & Disclaimer